vs

Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and SYNCHRONOSS TECHNOLOGIES INC (SNCR). Click either name above to swap in a different company.

IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $42.0M, roughly 1.1× SYNCHRONOSS TECHNOLOGIES INC). SYNCHRONOSS TECHNOLOGIES INC runs the higher net margin — 13.8% vs -4.8%, a 18.6% gap on every dollar of revenue. On growth, SYNCHRONOSS TECHNOLOGIES INC posted the faster year-over-year revenue change (-2.2% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $39.0M). Over the past eight quarters, SYNCHRONOSS TECHNOLOGIES INC's revenue compounded faster (0.7% CAGR vs -20.2%).

Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.

Synchronoss Technologies Inc develops cloud-based digital transformation, subscriber management and messaging solutions for global telecom operators and enterprise clients. Its core offerings support connectivity onboarding, IoT service enablement, with key markets spanning North America, Europe and Asia-Pacific.

IRWD vs SNCR — Head-to-Head

Bigger by revenue
IRWD
IRWD
1.1× larger
IRWD
$47.7M
$42.0M
SNCR
Growing faster (revenue YoY)
SNCR
SNCR
+45.1% gap
SNCR
-2.2%
-47.3%
IRWD
Higher net margin
SNCR
SNCR
18.6% more per $
SNCR
13.8%
-4.8%
IRWD
More free cash flow
IRWD
IRWD
$35.6M more FCF
IRWD
$74.6M
$39.0M
SNCR
Faster 2-yr revenue CAGR
SNCR
SNCR
Annualised
SNCR
0.7%
-20.2%
IRWD

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
IRWD
IRWD
SNCR
SNCR
Revenue
$47.7M
$42.0M
Net Profit
$-2.3M
$5.8M
Gross Margin
79.4%
Operating Margin
14.3%
14.0%
Net Margin
-4.8%
13.8%
Revenue YoY
-47.3%
-2.2%
Net Profit YoY
-200.9%
201.7%
EPS (diluted)
$0.01
$0.51

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRWD
IRWD
SNCR
SNCR
Q4 25
$47.7M
Q3 25
$122.1M
$42.0M
Q2 25
$85.2M
$42.5M
Q1 25
$41.1M
$42.2M
Q4 24
$90.5M
$44.2M
Q3 24
$91.6M
$43.0M
Q2 24
$94.4M
$43.5M
Q1 24
$74.9M
$43.0M
Net Profit
IRWD
IRWD
SNCR
SNCR
Q4 25
$-2.3M
Q3 25
$40.1M
$5.8M
Q2 25
$23.6M
$-19.6M
Q1 25
$-37.4M
$-3.8M
Q4 24
$2.3M
$7.9M
Q3 24
$3.6M
$-5.7M
Q2 24
$-860.0K
$-494.0K
Q1 24
$-4.2M
$4.5M
Gross Margin
IRWD
IRWD
SNCR
SNCR
Q4 25
Q3 25
79.4%
Q2 25
79.0%
Q1 25
79.4%
Q4 24
78.6%
Q3 24
79.1%
Q2 24
76.1%
Q1 24
76.2%
Operating Margin
IRWD
IRWD
SNCR
SNCR
Q4 25
14.3%
Q3 25
61.8%
14.0%
Q2 25
53.2%
16.1%
Q1 25
-70.7%
19.5%
Q4 24
34.8%
16.5%
Q3 24
28.0%
12.8%
Q2 24
26.5%
9.9%
Q1 24
14.7%
10.7%
Net Margin
IRWD
IRWD
SNCR
SNCR
Q4 25
-4.8%
Q3 25
32.8%
13.8%
Q2 25
27.7%
-46.1%
Q1 25
-90.9%
-9.0%
Q4 24
2.5%
17.8%
Q3 24
4.0%
-13.3%
Q2 24
-0.9%
-1.1%
Q1 24
-5.6%
10.4%
EPS (diluted)
IRWD
IRWD
SNCR
SNCR
Q4 25
$0.01
Q3 25
$0.23
$0.51
Q2 25
$0.14
$-1.87
Q1 25
$-0.23
$-0.37
Q4 24
$0.03
$0.75
Q3 24
$0.02
$-0.56
Q2 24
$-0.01
$0.01
Q1 24
$-0.03
$0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRWD
IRWD
SNCR
SNCR
Cash + ST InvestmentsLiquidity on hand
$215.5M
$34.8M
Total DebtLower is stronger
$163.2M
Stockholders' EquityBook value
$-261.8M
$55.4M
Total Assets
$396.9M
$278.2M
Debt / EquityLower = less leverage
2.95×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRWD
IRWD
SNCR
SNCR
Q4 25
$215.5M
Q3 25
$140.4M
$34.8M
Q2 25
$92.9M
$24.6M
Q1 25
$108.5M
$29.1M
Q4 24
$88.6M
$33.4M
Q3 24
$88.2M
$25.2M
Q2 24
$105.5M
$23.6M
Q1 24
$121.5M
$19.1M
Total Debt
IRWD
IRWD
SNCR
SNCR
Q4 25
Q3 25
$199.5M
$163.2M
Q2 25
$199.3M
$186.2M
Q1 25
$199.2M
$187.0M
Q4 24
$199.0M
$186.7M
Q3 24
$198.8M
$186.4M
Q2 24
$198.6M
$186.2M
Q1 24
$398.3M
$136.6M
Stockholders' Equity
IRWD
IRWD
SNCR
SNCR
Q4 25
$-261.8M
Q3 25
$-264.2M
$55.4M
Q2 25
$-308.2M
$49.4M
Q1 25
$-334.1M
$35.4M
Q4 24
$-301.3M
$29.8M
Q3 24
$-311.3M
$35.3M
Q2 24
$-321.7M
$30.6M
Q1 24
$-330.5M
$24.0M
Total Assets
IRWD
IRWD
SNCR
SNCR
Q4 25
$396.9M
Q3 25
$396.1M
$278.2M
Q2 25
$342.9M
$291.4M
Q1 25
$327.2M
$293.3M
Q4 24
$350.9M
$293.8M
Q3 24
$389.5M
$299.7M
Q2 24
$395.6M
$295.7M
Q1 24
$438.8M
$298.5M
Debt / Equity
IRWD
IRWD
SNCR
SNCR
Q4 25
Q3 25
2.95×
Q2 25
3.77×
Q1 25
5.28×
Q4 24
6.27×
Q3 24
5.28×
Q2 24
6.08×
Q1 24
5.70×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRWD
IRWD
SNCR
SNCR
Operating Cash FlowLast quarter
$74.6M
$39.4M
Free Cash FlowOCF − Capex
$74.6M
$39.0M
FCF MarginFCF / Revenue
156.3%
92.9%
Capex IntensityCapex / Revenue
0.0%
0.9%
Cash ConversionOCF / Net Profit
6.77×
TTM Free Cash FlowTrailing 4 quarters
$127.0M
$53.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRWD
IRWD
SNCR
SNCR
Q4 25
$74.6M
Q3 25
$47.6M
$39.4M
Q2 25
$-15.1M
$2.3M
Q1 25
$20.0M
$293.0K
Q4 24
$15.2M
$13.1M
Q3 24
$9.9M
$3.4M
Q2 24
$33.5M
$11.3M
Q1 24
$45.0M
$527.0K
Free Cash Flow
IRWD
IRWD
SNCR
SNCR
Q4 25
$74.6M
Q3 25
$47.6M
$39.0M
Q2 25
$-15.1M
$2.0M
Q1 25
$19.9M
$-31.0K
Q4 24
$12.2M
Q3 24
$9.9M
$3.2M
Q2 24
$33.4M
$10.9M
Q1 24
$44.9M
$10.0K
FCF Margin
IRWD
IRWD
SNCR
SNCR
Q4 25
156.3%
Q3 25
39.0%
92.9%
Q2 25
-17.7%
4.6%
Q1 25
48.4%
-0.1%
Q4 24
27.6%
Q3 24
10.8%
7.5%
Q2 24
35.4%
25.2%
Q1 24
60.0%
0.0%
Capex Intensity
IRWD
IRWD
SNCR
SNCR
Q4 25
0.0%
Q3 25
0.0%
0.9%
Q2 25
0.0%
0.8%
Q1 25
0.1%
0.8%
Q4 24
0.0%
1.9%
Q3 24
0.0%
0.3%
Q2 24
0.1%
0.9%
Q1 24
0.1%
1.2%
Cash Conversion
IRWD
IRWD
SNCR
SNCR
Q4 25
Q3 25
1.19×
6.77×
Q2 25
-0.64×
Q1 25
Q4 24
6.74×
1.66×
Q3 24
2.71×
Q2 24
Q1 24
0.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRWD
IRWD

Segment breakdown not available.

SNCR
SNCR

Subscription Services$39.4M94%
Professional Services$2.6M6%

Related Comparisons